Skip to content
  • Sunday, 26 July 2026
  • 3:41 am
  • Follow Us
Lab DB
  • Home
  • About Us
    • About Us
    • Affiliate Disclosure
    • Cookie Policy
    • Disclaimer
    • Privacy Policy
    • DMCA
    • Terms of Service
  • Contact Us
  • FAQ
  • Home
  • UCLA Researchers Advance EGFR-Targeted Drug for Glioblastoma into Clinical Testing
Laboratory Automation & Robotics

UCLA Researchers Advance EGFR-Targeted Drug for Glioblastoma into Clinical Testing

Lana Keisha May 5, 2026 0

Researchers at UCLA have achieved a significant milestone in the arduous fight against glioblastoma, a notoriously aggressive and lethal form…

Read More
Stem Cell & Regenerative Medicine

University of Basel Researchers Engineer First Fully Human Synthetic Bone Marrow Model to Advance Cancer Research and Reduce Animal Testing

Dwi Wanna Apr 29, 2026 0

In a landmark achievement for regenerative medicine and oncology, a multidisciplinary team of scientists at the University of Basel and…

Read More
Stem Cell & Regenerative Medicine

Indiana University Researchers Revolutionize Bone Marrow Imaging with Breakthrough Multiplex Technique to Advance Disease Research

Dwi Wanna Apr 25, 2026 0

In a significant stride for hematological research and regenerative medicine, scientists at the Indiana University School of Medicine have successfully…

Read More
Advanced Materials Science

Scientists Engineer Stable Optical Tornadoes in Miniature Structures Using Liquid Crystals and Synthetic Magnetic Fields to Advance Quantum Photonics

Nila Kartika Wati Apr 25, 2026 0

In a significant leap for the field of photonics, an international team of researchers has successfully demonstrated the creation of…

Read More
Clinical Diagnostics & Pathology

Labcorp and Children’s Hospital of Philadelphia Forge Strategic Alliance to Advance Pediatric Diagnostics and National Access

Reynand Amr Wu Apr 25, 2026 0

Labcorp, a leading global life sciences company, and the Children’s Hospital of Philadelphia (CHOP), a preeminent pediatric research and clinical…

Read More
Pharmaceutical R&D

Terremoto Biosciences Secures $108 Million Series C to Advance Next-Generation AKT1 Inhibitors for Oncology and Rare Diseases

Teuku Ryan Apr 16, 2026 0

Terremoto Biosciences, a pioneering biotechnology company at the forefront of developing novel therapeutics targeting the PI3K/AKT pathway, announced today the…

Read More
Pharmaceutical R&D

Regeneron Pharmaceuticals and Telix Pharmaceuticals Forge Strategic Alliance to Advance Precision Oncology Through Radiopharmaceutical Innovation

Teuku Ryan Apr 14, 2026 0

Regeneron Pharmaceuticals and Telix Pharmaceuticals have announced a significant partnership aimed at accelerating the development and commercialization of novel radiopharmaceutical…

Read More
Pharmaceutical R&D

Sidewinder Therapeutics Secures $137 Million in Series B Financing to Advance Bispecific Antibody-Drug Conjugate Pipeline

Teuku Ryan Apr 8, 2026 0

Sidewinder Therapeutics has announced the successful closure of a substantial $137 million Series B financing round, a significant development signaling…

Read More
Stem Cell & Regenerative Medicine

Indiana University School of Medicine Scientists Develop Breakthrough Imaging Technique for Bone Marrow Analysis to Advance Disease Treatment

Dwi Wanna Apr 3, 2026 0

The landscape of hematological research and regenerative medicine has undergone a significant transformation following a major technological breakthrough by researchers…

Read More
Stem Cell & Regenerative Medicine

University of Basel Researchers Replicate Human Bone Marrow in Landmark Study to Advance Blood Cancer Research and Reduce Animal Testing

Dwi Wanna Mar 30, 2026 0

In a significant breakthrough for regenerative medicine and oncology, researchers at the University of Basel and University Hospital Basel have…

Read More

Posts pagination

1 2 3 4
Science News: Empowering Public Understanding of Science, Medicine, and Technology Since 1921A Landmark Cellular Atlas Unveils the Synchronized Symphony of Aging Across Mammalian TissuesMulticomponent Self Interacting Dark Matter Model Offers New Solution to Longstanding Cosmological MysteriesBiopharma M&A Surges as Billion-Dollar Deals Fuel Pipeline Replenishment Amidst Patent Cliff Pressures
MEDVi Under Scrutiny: AI-Powered Telehealth Startup Faces FDA Warnings, Deceptive Marketing Allegations, and Multiple Lawsuits Despite Meteoric GrowthLLMOps in 2026: The 10 Tools Every Team Must HaveJapan’s FY26 NHI Drug Price Revision: Deeper Dive into Mechanisms and Market ImpactThe Most Favored Nation (MFN) Policy’s Unforeseen Ripple Effect: European Pharmaceutical Launches and Withdrawals Plummet
Remepy, a startup that pairs drugs with AI-driven apps, clears a Phase IIa test in Parkinson’sKing’s College London Researchers Identify Potential Breakthrough Alzheimer’s Treatment Through Repurposed Spinal Cord Injury Drug KCL-286Living Plastics That Self-Destruct: Scientists Engineer Microbe-Embedded Polymers for Complete and Rapid DecompositionSanofi Discontinues Amlitelimab Development in Atopic Dermatitis, Citing Lack of Meaningful Differentiation
YOU MAY HAVE MISSED
Laboratory Automation & Robotics
Remepy, a startup that pairs drugs with AI-driven apps, clears a Phase IIa test in Parkinson’s
Lana Keisha Jul 25, 2026
Neuroscience & Brain Research
King’s College London Researchers Identify Potential Breakthrough Alzheimer’s Treatment Through Repurposed Spinal Cord Injury Drug KCL-286
Rifan Muazin Jul 25, 2026
Advanced Materials Science
Living Plastics That Self-Destruct: Scientists Engineer Microbe-Embedded Polymers for Complete and Rapid Decomposition
Nila Kartika Wati Jul 25, 2026
Pharmaceutical R&D
Sanofi Discontinues Amlitelimab Development in Atopic Dermatitis, Citing Lack of Meaningful Differentiation
Teuku Ryan Jul 25, 2026

Copyright © 2025 | Powered by WordPress | News Gadgets by ThemeArile

  • Home
  • About Us
    • About Us
    • Affiliate Disclosure
    • Cookie Policy
    • Disclaimer
    • Privacy Policy
    • DMCA
    • Terms of Service
  • Contact Us
  • FAQ